---
category: news
title: "Lantern Pharma and TTC Oncology Establish AI Collaboration to Expand the Clinical Development of Drug Candidate TTC-352"
excerpt: "Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR ® artificial intelligence (\"AI\") and machine learning (“ML”) platform to transform the cost, pace,"
publishedDateTime: 2023-02-27T11:59:00Z
originalUrl: "https://markets.buffalonews.com/buffnews/article/bizwire-2023-2-27-lantern-pharma-and-ttc-oncology-establish-ai-collaboration-to-expand-the-clinical-development-of-drug-candidate-ttc-352"
webUrl: "https://markets.buffalonews.com/buffnews/article/bizwire-2023-2-27-lantern-pharma-and-ttc-oncology-establish-ai-collaboration-to-expand-the-clinical-development-of-drug-candidate-ttc-352"
type: article
quality: 0
heat: 0
published: false

provider:
  name: The Buffalo News
  domain: buffalonews.com

topics:
  - AI in Healthcare
  - AI

related:
  - title: "Kiromic BioPharma Reports Favorable Deltacel™ Preclinical Pharmacology Results"
    excerpt: "Kiromic BioPharma, Inc. (NASDAQ: KRBP) (\"Kiromic\" or the \"Company\"), a clinical-stage fully-integrated biotherapeutics company using its proprietary DIAMOND ® artificial intelligence and data mining platform to develop cell therapies with a focus on immune-oncology,"
    publishedDateTime: 2023-02-28T15:12:00Z
    webUrl: "https://www.tmcnet.com/usubmit/-kiromic-biopharma-reports-favorable-deltaceltrade-preclinical-pharmacology-resul-/2023/02/28/9767757.htm"
    type: article
    provider:
      name: TMCnet
      domain: tmcnet.com
    quality: 0

secured: "p2Rv0t+j22ER7Nv7GCnWViqOoBdJMnQdqbxPSejU4quZMHf+nvZXQea5qMfSUU7idIunYbNa7q51CYCJrFNB/pIjU+7Gp/UkW0l7v5k3lGgt6T5/q4es2nDzB3UYZA3x+3UVqYKE+VpysOpT8vkZjBLCoq4Js8b9mYIoZgwb1I3kMwSVmeXXFweXMPj6ok2fciQn8n7dsBz7upDsbmlNe2M/kL9/dkDjSCKGEex4tiYzAaX+x/JAJWmak5pxyM5n+4rQc80yce9pdgRg2k4eNce8vLFcFVzeMiz1QlCvhG8Lu/7lGP2opx3BrNnKvj6tDpWm+XR4XMfTXF5hueAAegvHBmW6pARfVG1w3+POt2Y=;A7Z4bwtBOjbHIR/7ViC70A=="
---

